Prospective study of predictor for efficiency of treatment with Nintedanib for idiopathic pulmonary fibrosis
Not Applicable
- Conditions
- idiopathic pulmonary fibrosis
- Registration Number
- JPRN-UMIN000019751
- Lead Sponsor
- Kurume University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 95
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who fulfilled one of the following criteria 1. Pregnant women. 2. Patient who was determined as ineligible by the investigator or the subinvestigator. 3. Patients treated with the following drug at the start of observation. Corticosteroid (more than 10 mg per day in term of prednizolone) Immunosuppressant N-acetylcysteine Pirfenidone Study drug for idiopathic pulmonary fibrosis 4. Case with exclusion disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The correlation between serum periostin level and change of pulmonary function
- Secondary Outcome Measures
Name Time Method 1. The correlation between serum periostin level and clinical data except for pulmonary function 2. Predictors of overall survival and progression-free-survival